Clinical

Dataset Information

0

Flavopiridol in Treating Patients With Refractory Cancer

ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of flavopiridol in treating patients who have refractory cancer.

DISEASE(S): Prostatic Neoplasms,Prostate Cancer,Small Intestine Cancer,Angioimmunoblastic T-cell Lymphoma,Lymphoma,Intestinal Neoplasms,Unspecified Adult Solid Tumor, Protocol Specific

PROVIDER: 2006388 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer
| 2006177 | ecrin-mdr-crc
Clinical Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas
| 2006400 | ecrin-mdr-crc
Clinical Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
| 2003499 | ecrin-mdr-crc
Clinical Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
| 2006371 | ecrin-mdr-crc
Clinical Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer
| 2010295 | ecrin-mdr-crc
Clinical Pyroxamide in Treating Patients With Advanced Cancer
| 2008028 | ecrin-mdr-crc
Clinical Irinotecan in Treating Patients With Colorectal Cancer
| 2003322 | ecrin-mdr-crc
Clinical Irofulven in Treating Patients With Metastatic Colorectal Cancer
| 2002970 | ecrin-mdr-crc
Clinical Irinotecan in Treating Patients With Metastatic Colorectal Cancer
| 2003060 | ecrin-mdr-crc
Clinical Gemcitabine in Treating Patients With Advanced Colorectal Cancer
| 2005648 | ecrin-mdr-crc